TMC Life Sciences Berhad Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

TMC Life Sciences Berhad ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 0.6%.

Wichtige Informationen

0.6%

Dividendenausschüttung

14%

Ausschüttungsquote

Durchschnittlicher Branchenertrag	1.7%
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	n/a
Gewinn pro Aktie	RM 0.03
Erwartete Dividendenrendite in 3 Jahren	n/a

Aktuelle Dividendenentwicklung

Recent updates

TMC Life Sciences Berhad (KLSE:TMCLIFE) Seems To Use Debt Quite Sensibly

Feb 14

We Think TMC Life Sciences Berhad (KLSE:TMCLIFE) Can Stay On Top Of Its Debt

Sep 29

Investors Met With Slowing Returns on Capital At TMC Life Sciences Berhad (KLSE:TMCLIFE)

Aug 26

TMC Life Sciences Berhad (KLSE:TMCLIFE) Shareholders Will Want The ROCE Trajectory To Continue

May 26

TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Feb 09

Returns On Capital - An Important Metric For TMC Life Sciences Berhad (KLSE:TMCLIFE)

Jan 13

Would Shareholders Who Purchased TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Three Years Be Happy With The Share price Today?

Dec 22

Should You Use TMC Life Sciences Berhad's (KLSE:TMCLIFE) Statutory Earnings To Analyse It?

Dec 02

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: TMCLIFE zahlt keine nennenswerte Dividende für den Markt MY, daher muss nicht geprüft werden, ob die Zahlungen stabil sind.

Wachsende Dividende: TMCLIFE zahlt keine nennenswerte Dividende für den Markt MY, daher muss nicht geprüft werden, ob die Zahlungen steigen.

Dividendenrendite im Vergleich zum Markt

TMC Life Sciences Berhad Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von TMCLIFE im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (TMCLIFE)	0.6%
Untere 25 % des Marktes (MY)	1.7%
Markt Top 25 % (MY)	4.6%
Branchendurchschnitt (Healthcare)	1.7%
Analystenprognose in 3 Jahren (TMCLIFE)	n/a

Bemerkenswerte Dividende: TMCLIFEDie Dividende des Unternehmens (0.6%) ist im Vergleich zu den unteren 25 % der Dividendenzahler auf dem Markt MY (1.84%) nicht bemerkenswert.

Hohe Dividende: TMCLIFEDie Dividende des Unternehmens (0.6%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt MY (4.58%) niedrig.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: TMCLIFE zahlt keine nennenswerte Dividende für den Markt MY.

Barausschüttung an die Aktionäre

Cashflow-Deckung: TMCLIFE zahlt keine nennenswerte Dividende für den Markt MY.

TMC Life Sciences Berhad Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Aktuelle Dividendenentwicklung

TMC Life Sciences Berhad Announces Single-Tier Final Dividend Per Ordinary Share for the Financial Year Ended 30 June 2023, Payable on 03 January 2024

TMC Life Sciences Berhad Proposes Single-Tier Final Dividend for the Financial Year Ended 30 June 2022, Payable on 03 January 2023

Recent updates

Third quarter 2024 earnings released: EPS: RM0.006 (vs RM0.008 in 3Q 2023)

Second quarter 2024 earnings released: EPS: RM0.008 (vs RM0.003 in 2Q 2023)

TMC Life Sciences Berhad Announces Redesignation of Dr Heng Jun Li Melvin from Non Executive Director to Group Chief Executive Officer

First quarter 2024 earnings released: EPS: RM0.009 (vs RM0.004 in 1Q 2023)

TMC Life Sciences Berhad Announces Redesignation of Kan Kheong Ng as Executive Vice Chairman

TMC Life Sciences Berhad, Annual General Meeting, Nov 02, 2023

TMC Life Sciences Berhad Announces Single-Tier Final Dividend Per Ordinary Share for the Financial Year Ended 30 June 2023, Payable on 03 January 2024

Full year 2023 earnings released: EPS: RM0.023 (vs RM0.024 in FY 2022)

High number of new directors

Tmc Life Sciences Berhad Announces Appointment of Dato' Mohd Sheridan Bin Ramli as Independent and Non Executive Director

TMC Life Sciences Berhad Announces Redesignation of Cheah Ho Chee as Independent and Non Executive Chairman of Risk Committee

Third quarter 2023 earnings released: EPS: RM0.008 (vs RM0.004 in 3Q 2022)

TMC Life Sciences Berhad Announces Appointment of Puan Mazrina Binti Arifin as Independent and Non Executive Director

TMC Life Sciences Berhad (KLSE:TMCLIFE) Seems To Use Debt Quite Sensibly

Second quarter 2023 earnings released: EPS: RM0.003 (vs RM0.004 in 2Q 2022)

TMC Life Sciences Berhad Appoints Dr. Heng Jun Li Melvin as Non Independent and Non Executive Director

TMC Life Sciences Berhad Reports Write Offs for the Quarter Ended September 30, 2022

First quarter 2023 earnings released: EPS: RM0.004 (vs RM0.002 in 1Q 2022)

TMC Life Sciences Berhad Announces Appointment of June Leong Lai Ling as Independent and Non Executive Member of Audit Committee

TMC Life Sciences Berhad, Annual General Meeting, Nov 03, 2022

We Think TMC Life Sciences Berhad (KLSE:TMCLIFE) Can Stay On Top Of Its Debt

Full year 2022 earnings released: EPS: RM0.024 (vs RM0.012 in FY 2021)

Investors Met With Slowing Returns on Capital At TMC Life Sciences Berhad (KLSE:TMCLIFE)

TMC Life Sciences Berhad Proposes Single-Tier Final Dividend for the Financial Year Ended 30 June 2022, Payable on 03 January 2023

TMC Life Sciences Berhad Appoints Cheah Ho Chee as Independent and Non Executive Director

TMC Life Sciences Berhad Announces CFO Changes

Third quarter 2022 earnings released: EPS: RM0.004 (vs RM0.002 in 3Q 2021)

Insufficient new directors

Insufficient new directors

Insufficient new directors

TMC Life Sciences Berhad Announces Re-Designation of Wong Yu Chee as Group Chief Accounting Officer from Group Chief Financial Officer

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Director Lee George Lam has joined 10th company board

Director Lee George Lam has joined 10th company board

Director Lee George Lam has joined 10th company board

Director Lee George Lam has joined 10th company board

Director Lee George Lam has joined 10th company board

Director Lee George Lam has joined 10th company board

Director Lee George Lam has joined 10th company board

Director Lee George Lam has joined 10th company board

Full year 2021 earnings released: EPS RM0.012 (vs RM0.009 in FY 2020)

TMC Life Sciences Berhad (KLSE:TMCLIFE) Shareholders Will Want The ROCE Trajectory To Continue

New 90-day high: RM0.79

TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

New 90-day high: RM0.68

Returns On Capital - An Important Metric For TMC Life Sciences Berhad (KLSE:TMCLIFE)

TMC Life Sciences Berhad Announces Re-Designation of Dato' Sri Mohd Mokhtar Bin Mohd Shariff as Independent Non-Executive Chairman

New 90-day high: RM0.60

Would Shareholders Who Purchased TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Three Years Be Happy With The Share price Today?

Should You Use TMC Life Sciences Berhad's (KLSE:TMCLIFE) Statutory Earnings To Analyse It?

New 90-day high: RM0.54

New 90-day low - RM0.48

Full year earnings released - EPS RM0.0091

Stabilität und Wachstum des Zahlungsverkehrs

Dividendenrendite im Vergleich zum Markt

Gewinnausschüttung an die Aktionäre

Barausschüttung an die Aktionäre

Entdecken Sie dividendenstarke Unternehmen